Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.
Aquaporin water channels in the nervous system.
[Present and future of the transcranial magnetic stimulation].
Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis.
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
Multiple sclerosis: Lessons from molecular neuropathology.
Human Wharton?s jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis.
Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.
[Treatment of multiple sclerosis symptoms and exacerbations].
Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.
Myelitis: Differences between multiple sclerosis and other aetiologies.
Tried-and-True Antibiotic May Block Conversion to MS
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS.
Expanded Disability Status Scale-Based Disability and Dental-Periodontal Conditions in Patients with Multiple Sclerosis.
Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
[Research progresses of monoclonal antibodies therapy in neuromyelitis optica].
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
Adaptive voxel, texture and temporal conditional random fields for detection of Gad-enhancing multiple sclerosis lesions in brain MRI.
Repeated measurement of the attention components of patients with multiple sclerosis using the Attention Network Test-Interaction (ANT-I): Stability, isolability, robustness, and reliability.
Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version.
Functional relevance for multiple sclerosis-associated genetic variants.
Neurodegenerative diseases and therapeutic strategies using iron chelators.
Identifying and addressing unmet therapeutic needs in MS.
EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy.
Pages
« first
‹ previous
…
373
374
375
376
377
378
379
380
381
…
next ›
last »